Injective's INJ is no longer attractive enough to compete with newer Layer 1 projects, in reply to @DukeD_Defi's case that the market misprices it as an onchain capital-markets chain. x.comÂ
Karamata_
Crypto Researcher, Ambassador for TON & Arbitrum
Movement Labs' Chapter 11 filing is one more group of grifters finally getting margin called, and the rest of the scammy, overvalued alt L1s will go the way of the dodo, same as Movement. x.comÂ
XION is priced like a small L1 while it builds for consumer adoption and internet-scale verification, so it could be one of the more mispriced assets if crypto moves toward walletless apps, proofs and anti-bot systems. Account abstraction lets users onboard with Google, Apple, email or passkeys without wallets or gas, and the 2026 upgrade added native ZK verification. Backed by $36M+ from Multicoin, Animoca and others, it trades far below its funding and traction, though price action is weak. … Show more
Injective faces no large early-investor unlock that could add selling pressure over the long term. All of its token supply is already circulating, with market cap equal to fully diluted value; that makes holding it a healthier long-term proposition than RWA layer-1 tokens with an unlock cliff. x.com x.comÂ
Sui is quickly becoming a ghost chain despite strong technology, because terrible token economics and founder greed hold it back. Over six months, chain fees fell 90%, TVL 70%, DEX and perp volume over 90% and daily active addresses 85%, while market cap fell only about 50%. Cheaper gas explains some of the fee drop but not the combined decline. Founders control the unallocated supply, giving them over 80% of tokens. Sui should chase trading and DeFi, crypto's best product-market fit. x.com … Show more
NEAR feels like an older, inflationary tech coin that has had its time in the sun, even if the case makes some sense on paper. A post the author replies to describes selling all NEAR and rotating into Zcash and Hyperliquid because conviction in it never grew. x.comÂ
Injective could attract repeat traders and generate fees to support INJ buybacks and burns as it adds markets and trading tools. SICI is live for trading GPU rental prices; options for SICI, US indexes and commodities are on testnet, and developers can build options apps on the same infrastructure. BDACS is working to bring KRW1 settlement to its RWA markets, subject to regulatory approval. INJ deserves a place on the watchlist. x.comÂ
Aster's ceiling looks low because its rival Hyperliquid has captured TradFi and real-world assets, leaving Aster to bet on small-cap, high-volatility crypto. That is a self-downgrade: this cycle has had no broad altseason, and even future 10x or 100x hot spots tend to draw one-wave capital and users with poor stickiness, as with NFTs and inscriptions. Even with Binance and CZ as a floor, the gap with the leader will likely widen, and its founder seems to lack confidence. x.com x.comÂ
Cardano is hollow, with high costs and low usage, and the shutdown of TapTools, one of its main data and infrastructure platforms, is a leading indicator that apps will follow. It sold decentralization and research for years while deferring speed, UX and incentives, lacking the builder culture that carried Ethereum and Solana. Its value has fallen from about $95B to roughly $8B, and founder Charles Hoskinson warned more Cardano DeFi projects could die in late 2026, per Coin Bureau. x.com x.com … Show more
Injective's Meridian mainnet upgrade is the upgrade that sends INJ to $20. Per @NinjaCatSF, it brings better support for tokenized real-world assets, smoother trading across the Injective ecosystem, stronger market infrastructure and groundwork for private institutional trading. INJ feels like Near before its hype, with the vision coming together. x.com x.comÂ
Ether and Solana lack a path to profitability, which any sound investment should have, so severe underperformance is happening and will continue. x.comÂ